Please use this identifier to cite or link to this item: https://repositorio.unifesp.br/handle/11600/29475
Title: Expression of antibodies directed to Paracoccidioides brasiliensis glycosphingolipids during the course of paracoccidioidomycosis treatment
Authors: Bertini, Silvio [UNIFESP]
Colombo, Arnaldo L. [UNIFESP]
Takahashi, Helio K. [UNIFESP]
Straus, Anita H. [UNIFESP]
Universidade Federal de São Paulo (UNIFESP)
Issue Date: 1-Feb-2007
Publisher: Amer Soc Microbiology
Citation: Clinical and Vaccine Immunology. Washington: Amer Soc Microbiology, v. 14, n. 2, p. 150-156, 2007.
Abstract: Paracoccidioidomycosis (PCM) is a granulomatous disease caused by the dimorphic fungus Paracoccidioides brasiliensis. the immunoglobulin classes and isotypes of antibodies directed to acidic glycosphingolipids (GSLs) and glucosylceramide of P. brasiliensis were determined by enzyme-linked immunosorbent assay of sera from 31 PCM patients. the reactivities of 38 serum samples were analyzed by considering the stage of treatment: before antifungal treatment (n = 10), during 1 to 4 months of treatment (T1-4; n = 9), during 5 to 12 months of treatment (T5-12; n = 9), and posttreatment (PT; n = 10). Sera from healthy subjects (n = 12) were used as controls. Only the GSL Pb-1 antigen, which presents the carbohydrate structure Galf beta 1-6(Man alpha 1-3)Man beta 1, was reactive with the PCM patient sera. the PCM patient sera did not react with Pb-2, which lacks the Galf residue and which is considered the biosynthetic precursor of Pb-1, indicating that the Galf residue is essential for antibody reactivity. the Pb-1 glycolipid from nontreated patients elicited a primary immune response with immunoglobulin M (IgM) production and subsequent switching to IgG1 production. the IgG1 titer increased after the start of antifungal treatment (T1-4 group), and general decreases in the anti-Pb-1 antibody titers were observed after 5 months of treatment (T5-12 and PT groups). the Pb-1 antigen, an acidic GSL with terminal Galf residue, has potential application as an elicitor of the host immune response in patients with PCM.
URI: http://repositorio.unifesp.br/handle/11600/29475
ISSN: 1556-6811
Other Identifiers: http://dx.doi.org/10.1128/CVI.00285-06
Appears in Collections:Em verificação - Geral

Files in This Item:
File Description SizeFormat 
WOS000244508700007.pdf330.87 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.